Catherine C Hedrick
Overview
Explore the profile of Catherine C Hedrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
9378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuboi N, Rivera-Caraballo K, Sahu U, Pacholczyk R, Douglass E, Johnson T, et al.
Mol Cancer Ther
. 2024 Dec;
24(3):444-452.
PMID: 39711419
Glioblastoma (GBM) is the most frequent malignant brain tumor. We recently discovered that oncolytic herpes simplex virus engineered to disable tumor-intrinsic protein kinase R (PKR) signaling (oHSV-shPKR) could increase oHSV...
2.
Suthahar S, Nettersheim F, Alimadadi A, Wang E, Billitti M, Resto-Trujillo N, et al.
Cardiovasc Res
. 2024 Sep;
120(13):1577-1589.
PMID: 39229899
Aims: Olfactory receptor 2 (Olfr2) has been identified in a minimum of 30% of vascular macrophages, and its depletion was shown to reduce atherosclerosis progression. Mononuclear phagocytes, including monocytes and...
3.
4.
Pattarabanjird T, Nguyen A, McSkimming C, Dinh H, Marshall M, Ghosheh Y, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(12):1328.
PMID: 39196158
No abstract available.
5.
Pattarabanjird T, Nguyen A, McSkimming C, Dinh H, Marshall M, Ghosheh Y, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(11):1003-1014.
PMID: 39196097
IgMs that inactivate oxidation-specific epitopes (IgM), which are secondary products of lipid peroxidization, protect against inflammatory diseases, including diet-induced atherosclerosis. However, the human B cell subtype that produces IgM remains...
6.
Mathews I, Saminathan P, Henglin M, Liu M, Nadig N, Fang C, et al.
medRxiv
. 2024 Aug;
PMID: 39148854
Immune related adverse events (irAEs) after immune checkpoint blockade (ICB) therapy occur in a significant proportion of cancer patients. To date, the circulating mediators of ICB-irAEs remain poorly understood. Using...
7.
Makram O, Okwuosa T, Addison D, Cortes J, Dent S, Bevel M, et al.
J Am Heart Assoc
. 2024 Jul;
13(15):e035500.
PMID: 39056333
Background: Both cancer and cardiovascular disease (CVD) are the leading causes of death worldwide. Although our previous study detected a relationship between CVD and cancer incidence, limited evidence is available...
8.
Akkari L, Amit I, Bronte V, Fridlender Z, Gabrilovich D, Ginhoux F, et al.
Nat Rev Immunol
. 2024 Jul;
24(12):850-857.
PMID: 38969773
No abstract available.
9.
Makram O, Kunhiraman H, Harris R, Hedrick C, Nasir K, Weintraub N, et al.
Am Heart J Plus
. 2024 Apr;
40:100380.
PMID: 38586433
Introduction: This study aimed to investigate the relationship between risk factors of cancer among individuals with existing cardiovascular disease (CVD). Methods: The analysis included 438 and 2100 CVD patients aged...
10.
Chatterjee N, Komaravolu R, Durant C, Wu R, McSkimming C, Drago F, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474140
Monocytes are associated with human cardiovascular disease progression. Monocytes are segregated into three major subsets: classical (cMo), intermediate (iMo), and nonclassical (nMo). Recent studies have identified heterogeneity within each of...